Bevacizumab
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Bevacizumab is an antibody that targets VEGF.[1]
It was first used in colorectal carcinoma but now used for a number of other tumours.[2]
References
- ↑ Toon, CW.; Hasovits, C.; Paik, J.; Field, M.; Chou, A.; Hugh, TJ.; Pavlakis, N.; Gill, AJ. (Jul 2014). "Skin rash, a kidney mass and a family mystery dating back to World War II.". Med J Aust 201 (1): 58-60. PMID 24999901.
- ↑ URL: http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607001.html. Accessed on: October 20, 2014.